At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
EXAI Exscientia plc
Post-Market Trading 05-13 17:32:58 EDT
4.91
+0.30
+6.51%
盘后4.85
-0.06-1.22%
16:44 EDT
High4.99
Low4.70
Vol504.13K
Open4.70
D1 Closing4.61
Amplitude6.29%
Mkt Cap620.50M
Tradable Cap455.50M
Total Shares126.37M
T/O2.46M
T/O Rate0.54%
Tradable Shares92.77M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
AI-discovered drugs have an 80%–90% success rate: study
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company's platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.